FRIDAY, July 25, 2025 (HealthDay News) — Veterans who receive traumatic brain injuries in combat often experience crippling post-traumatic stress disorder, anxiety and depression, leaving them hopeless and potentially suicidal. But help might be on the way from an unlikely source – a psychedelic drug called ibogaine. The drug, derivedContinue Reading

THURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as “subpotent” active ingredients. The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect June 20, wasContinue Reading

THURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE). CHE is common condition marked by redness, itching and cracking on the hands and wrists. Anzupgo (delgocitinib cream) is approved for adults with moderate-to-severe CHEContinue Reading